Please assess the completion status of the following clinical trial:

Trial Title: Prophylaxis Versus On-demand Therapy Through Economic Report

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* age ≥ 12 years and ≤ 55 years~* severe haemophilia A (FVIII \< 1%)~* absence of inhibitors (Bethesda titre \< 0.6 BU/ml)~* Previous Treated Patients (prior exposure days \> 200)~* Kogenate Bayer administered 20-30 IU/kg -3 times a week, for the prophylaxis group~* ≥ 6 joint bleeds requiring treatment with FVIII concentrates in the previous 6 months before enrollment, for on-demand group~* written informed consent~Exclusion Criteria:~* concomitant severe and chronic diseases or congenital skeletal malformation~* unreliability of patient or likelihood of follow-up failure~* presence of inhibitors or history of inhibitors (in the previous 2 years)~* currently on immune tolerance treatment~* hepatic cirrhosis or liver disease in rapid progression~* AIDS~* platelet count \< 75,000/mm3~* presence of conditions that influence negatively patient´s compliance~* participation in another study

- Gender: ALL
- Minimum Age: 12 Years
- Maximum Age: 55 Years
- Healthy Volunteers: f

Study Arms:
- Group 1 (Type: None): None
- Group 2 (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).